Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain
Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company applying its proprietary targeted protein degradation uSMITE™ platform to discover and advance therapeutics for the ...
News Medical on MSN19h
Telephone therapy alleviates fatigue and improves quality of life for breast cancer survivors
With medical advances, more than 169,000 people in the United States are living with metastatic breast cancer.
Psychology Today23h
Psychotherapy Isn't Nonsense
Psychotherapy, by and large, is based on the biopsychosocial model. Despite these rich underpinnings, it is still at times ...
San Diego Union-Tribune20h
San Diego Union-Tribune
📷 Photos: Trump’s inauguration 🐍 Lunar New Year events 🏠 Home insurance after the fires ⛰️ Hike of the week 🍽️ Hidden gem: BoujieMana The Lilac fire was reported around 12:45 a ...
Microsoft22h
Microsoft Trademark and Brand Guidelines
These Trademark and Brand Guidelines (“Trademark Guidelines”) detail how you can help us protect Microsoft’s brand assets, including logos, names ... Specific Brand and Product Guidelines linked above ...